Human carboxylesterases: an update on CES1, CES2 and CES3.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Protein Peptide Letters

• Publication date

  2009-09-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/092986609789071324PMID 19508181
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs

  2008cited by this paper
• Structural organization and characterization of the regulatory element of the human carboxylesterase (CES1A1 and CES1A2) genes.

  2008cited by this paper
• Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis.

  2008cited by this paper
• Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.

  2007cited by this paper
• Genomic Structure and Transcriptional Regulation of the Rat, Mouse, and Human Carboxylesterase Genes

  2007cited by this paper
• Expression and Characterization of a Human Carboxylesterase 2 Splice Variant

  2007cited by this paper
• Human carboxylesterase isozymes: catalytic properties and rational drug design.

  2006cited by this paper
• Entrez Gene: gene-centered information at NCBI

  2006cited by this paper
• Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small Intestine

  2006cited by this paper
• Development of bioinformatics resources for display and analysis of copy number and other structural variants in the human genome

  2006cited by this paper
• Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1.

  2006cited by this paper
• Structure, function and regulation of carboxylesterases.

  2006cited by this paper
• Function of alternative splicing.

  2005cited by this paper
• FUNCTIONAL CHARACTERIZATION OF THREE NATURALLY OCCURRING SINGLE NUCLEOTIDE POLYMORPHISMS IN THE CES2 GENE ENCODING CARBOXYLESTERASE 2 (HCE-2)

  2005cited by this paper
• The HUGO Gene Nomenclature Database, 2006 updates

  2005cited by this paper
• Mammalian carboxylesterases: from drug targets to protein therapeutics.

  2005cited by this paper
• Hydrolysis of Capecitabine to 5′-Deoxy-5-fluorocytidine by Human Carboxylesterases and Inhibition by Loperamide

  2005cited by this paper
• Alternative splicing in disease and therapy

  2004cited by this paper
• Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3.

  2004cited by this paper
• ESTHER, the database of the alpha/beta-hydrolase fold superfamily of proteins.

  2004cited by this paper
• Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 gene.

  2004cited by this paper
• Pharmacogenetics of human carboxylesterase 2, an enzyme involved in the activation of irinotecan into SN‐38

  2004cited by this paper
• Methylphenidate Is Stereoselectively Hydrolyzed by Human Carboxylesterase CES1A1

  2004cited by this paper
• Aberrant and Alternative Splicing in Cancer

  2004cited by this paper
• Pharmacogenomic assessment of carboxylesterases 1 and 2.

  2004cited by this paper
• Characterization of multiple promoters in the human carboxylesterase 2 gene.

  2003cited by this paper
• Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition.

  2003cited by this paper
• Catalog of 680 variations among eight cytochrome P450 (CYP) genes, nine esterase genes, and two other genes in the Japanese population

  2003cited by this paper
• Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme

  2003cited by this paper
• Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis.

  2003cited by this paper
• Lessons from a bacterial cocaine esterase

  2002cited by this paper
• Current progress on esterases: from molecular structure to function.

  2002cited by this paper
• Human carboxylesterases in term placentae: enzymatic characterization, molecular cloning and evidence for the existence of multiple forms.

  1999cited by this paper
• The mammalian carboxylesterases: from molecules to functions.

  1998cited by this paper
• Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver.

  1997cited by this paper
• Purification and Cloning of a Broad Substrate Specificity Human Liver Carboxylesterase That Catalyzes the Hydrolysis of Cocaine and Heroin*

  1997cited by this paper
• Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver.

  1997cited by this paper
• Carboxylesterase-mediated transesterification of meperidine (Demerol) and methylphenidate (Ritalin) in the presence of [2H6]ethanol: preliminary in vitro findings using a rat liver preparation.

  1997cited by this paper
• Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs.

  1997cited by this paper
• Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine.

  1994cited by this paper
• Glycosylation-dependent activity of baculovirus-expressed human liver carboxylesterases: cDNA cloning and characterization of two highly similar enzyme forms.

  1993cited by this paper
• Cloning and analysis of a cDNA encoding a human liver carboxylesterase.

  1991cited by this paper
• Human liver cocaine esterases: ethanol‐mediated formation of ethylcocaine

  1991cited by this paper
• A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases.

  1991cited by this paper
• Cocaethylene: A Unique Cocaine Metabolite Displays High Affinity for the Dopamine Transporter

  1991cited by this paper

• Polysorbates degrading enzymes in biotherapeutics – a current status and future perspectives

  2025cites this paper
• Esterase Profile: Structural, Functional and Evolutionary Aspects of Human and Animal Blood Esterases

  2025cites this paper
• Urantide alleviates lipopolysaccharide/D-galactosamine-induced acute liver failure through upregulating carboxylesterase1f in mice

  2025cites this paper
• Dimethyl Fumarate vs. Monomethyl Fumarate: Unresolved Pharmacologic Issues

  2025influential citation
• A human pan-disease blood atlas of the circulating proteome.

  2025cites this paper
• Mechanistic insights into human carboxylesterase 2 (CES2) inhibition by the CES1 prodrug substrate remdesivir.

  2025cites this paper
• Advances in selective targeting of serine hydrolases: A targeted covalent approach against hCES2A mitigates irinotecan toxicity in vivo

  2025cites this paper
• Loss of hepatic carboxylesterase 3 prevents the development of MASLD in mice

  2025cites this paper
• Discovery of orally active and serine-targeting covalent inhibitors against hCES2A for ameliorating irinotecan-triggered gut toxicity

  2025cites this paper
• Visualization of carboxylesterase 2 regulation in kidney injury via an enzyme-activated fluorescent probe

  2025cites this paper
• Transcriptomic Association Analysis of the Metabolic Mechanism of Sulfamethoxazole in Channel Catfish (Ictalurus punctatus)

  2024cites this paper
• Intestinal human carboxylesterase 2 (CES2) expression rescues drug metabolism and most metabolic syndrome phenotypes in global Ces2 cluster knockout mice

  2024cites this paper
• A spatiotemporal atlas of human spermatogenesis based on single-cell transcriptomics and multiplex antibody imaging

  2024cites this paper
• Ocular drug-metabolizing enzymes: focus on esterases

  2024cites this paper
• Pyrazolone compounds could inhibit CES1 and ameliorates fat accumulation during adipocyte differentiation.

  2024cites this paper
• Regulation of Human Hydrolases and Its Implications in Pharmacokinetics and Pharmacodynamics

  2024cites this paper
• Pharmacogenetic study of CES1 gene and enalapril efficacy

  2024cites this paper
• Drug Metabolism and Disposition: DMD-AR-2023-001365R1 Human carboxylesterase 1A plays a predominant role in hydrolysis of the anti-dyslipidemia agent fenofibrate in humans

  2023cites this paper
• Identification of the first selective bioluminescent probe for real-time monitoring of carboxylesterase 2 in vitro and in vivo.

  2023cites this paper
• 5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review).

  2023cites this paper
• Hepatic and ovarian effects of perfluorooctanoic acid exposure differ in lean and obese adult female mice.

  2023cites this paper
• The Biocatalysis in Cancer Therapy

  2023cites this paper
• CES1‐Triggered Liver‐Specific Cargo Release of CRISPR/Cas9 Elements by Cationic Triadic Copolymeric Nanoparticles Targeting Gene Editing of PCSK9 for Hyperlipidemia Amelioration

  2023cites this paper
• Discovery of seven-membered ring berberine analogues as highly potent and specific hCES2A inhibitors.

  2023cites this paper
• Insights into the Degradation of Polymer–Drug Conjugates by an Overexpressed Enzyme in Cancer Cells

  2023cites this paper
• Rational design of a NIR fluorescent probe for carboxylesterase 1 detection during endoplasmic reticulum stress and drug-induced acute liver injury.

  2023cites this paper
• Highly Sensitive “Off/On” EPR Probes to Monitor Enzymatic Activity

  2022cites this paper
• Deciphering the species differences in CES1A-mediated hydrolytic metabolism by using a bioluminescence substrate.

  2022cites this paper
• Selective detection of carboxylesterase 2 activity in cancer cells using an activity-based chemiluminescent probe.

  2022cites this paper
• Major implications of single nucleotide polymorphisms in human carboxylesterase 1 on substrate bioavailability

  2022cites this paper
• B-esterases characterisation in the digestive tract of the common octopus and the European cuttlefish and their in vitro responses to contaminants of environmental concern.

  2022cites this paper
• Gene expression correlates of advanced epigenetic age and psychopathology in postmortem cortical tissue

  2021cites this paper
• Human carboxylesterases and fluorescent probes to image their activity in live cells.

  2021cites this paper
• Pig Liver Esterases Hydrolyze Endocannabinoids and Promote Inflammatory Response

  2021cites this paper
• Carboxylesterases and arylacetamide deacetylase comparison in human A549, H460, and H727 pulmonary cells.

  2021cites this paper
• Carboxylesterase Activities and Protein Expression in Rabbit and Pig Ocular Tissues

  2021cites this paper
• Alternative splicing: An important regulatory mechanism in colorectal carcinoma

  2021cites this paper
• Drug Metabolism: Other Phase I Enzymes

  2021cites this paper
• Human Carboxylesterase 2 in Cocaine Metabolism

  2021cites this paper
• In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites.

  2021cites this paper
• Evaluating effects of black carrot extract on testicular carboxylesterase activity and oxidative stress parameters in rats exposed to Bisphenol A

  2021cites this paper
• Overexpressed CES2 has prognostic value in CRC and knockdown CES2 reverses L-OHP-resistance in CRC cells by inhibition of the PI3K signaling pathway.

  2020cites this paper
• Rational design of a novel aptamer-based biosensor for a target enzyme via modification of GFP-like fluorogens: Carboxylesterase 2A as a case study

  2020cites this paper
• Discovery of hCES2A inhibitors from Glycyrrhiza inflata via combination of docking-based virtual screening and fluorescence-based inhibition assays.

  2020cites this paper
• The Use of Complementary and Integrative Medicines and Exploring Natural Health Product-Drug Interactions In Vitro in the Management of Pediatric Attention-Deficit Hyperactivity Disorder

  2020influential citation
• Synthesis and Structure‐Activity Relationships of 3‐Arylisoquinolone Analogues as Highly Specific hCES2A Inhibitors

  2020cites this paper
• Interspecies variation of clopidogrel hydrolysis in liver microsomes from various manmmals.

  2020cites this paper
• Inhibitory effects of organophosphate esters on carboxylesterase activity of rat liver microsomes.

  2020cites this paper
• Genetic Analysis Reveals a Significant Contribution of CES1 to Prostate Cancer Progression in Taiwanese Men

  2020cites this paper
• A Pharmacokinetic and Pharmacodynamic Evaluation of the Anti-Hepatocellular Carcinoma Compound 4-N-Carbobenzoxy-gemcitabine (Cbz-dFdC)

  2020cites this paper
• Construction and application of a high-content analysis for identifying human carboxylesterase 2 inhibitors in living cell system

  2020cites this paper
• A magnetic SERS immunosensor for highly sensitive and selective detection of human carboxylesterase 1 in human serum samples.

  2020cites this paper
• Catalyst-free visible-light-induced condensation to synthesize bis(indolyl)methanes and biological activity evaluation of them as potent human carboxylesterase 2 inhibitors

  2019cites this paper
• Dosimetry considerations for in vivo and in vitro test data and a novel surrogate iTTC approach for read-across based on metabolites

  2019cites this paper
• Molecular theranostic based on esterase-mediated drug activation for hepatocellular carcinoma

  2019cites this paper
• Effects of methylphenidate on the aggressive behavior, serotonin and dopamine levels, and dopamine-related gene transcription in brain of male Nile tilapia (Oreochromis niloticus)

  2019cites this paper
• Inhibition of human carboxylesterases by magnolol: Kinetic analyses and mechanism.

  2019cites this paper
• Discovery of natural pentacyclic triterpenoids as potent and selective inhibitors against human carboxylesterase 1.

  2019cites this paper
• Cholinesterase and carboxylesterase inhibitors as pharmacological agents

  2019cites this paper
• Discovery of a highly specific and efficacious inhibitor of human carboxylesterase 2 by large-scale screening.

  2019cites this paper
• Synthesis, molecular docking, and biological evaluation of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher and natural alcohol moieties as new selective carboxylesterase inhibitors.

  2019cites this paper
• Catalytic Hydrolysis Mechanism of Cocaine by Human Carboxylesterase 1: An Orthoester Intermediate Slows Down the Reaction

  2019cites this paper
• Esterase is a powerful tool for the biodegradation of pyrethroid insecticides.

  2019cites this paper
• Carboxylesterases: Pharmacological Inhibition Regulated Expression and Transcriptional Involvement of Nuclear Receptors and other Transcription Factors

  2019cites this paper
• Breed Differences in Pig Liver Esterase (PLE) between Tongcheng (Chinese Local Breed) and Large White Pigs

  2018cites this paper
• Carboxylesterases: Sources, Characterizationand Broader Applications

  2018cites this paper
• The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics

  2018cites this paper
• N-bromosuccinimide mediated decarboxylative sulfonylation of β-keto acids with sodium sulfinates toward β-keto sulfones: Evaluation of human carboxylesterase 1 activity

  2018cites this paper
• Human carboxylesterases: a comprehensive review

  2018cites this paper
• Nevadensin is a naturally occurring selective inhibitor of human carboxylesterase 1.

  2018cites this paper
• ENCoRE: an efficient software for CRISPR screens identifies new players in extrinsic apoptosis

  2017cites this paper
• In vitro metabolism of the anti-inflammatory clerodane diterpenoid polyandric acid A and its hydrolysis product by human liver microsomes and recombinant cytochrome P450 and UDP-glucuronosyltransferase enzymes

  2017influential citation
• Glycoengineering of Esterase Activity through Metabolic Flux‐Based Modulation of Sialic Acid

  2017cites this paper
• Transcriptome of the GSH-Depleted Lens Reveals Changes in Detoxification and EMT Signaling Genes, Transport Systems, and Lipid Homeostasis

  2017cites this paper
• Prodrugs of triterpenoids and their derivatives.

  2017cites this paper
• Assessment of the inhibitory effects of pyrethroids against human carboxylesterases

  2017cites this paper
• Carboxylesterases in lipid metabolism: from mouse to human

  2017influential citation
• Identification and characterization of naturally occurring inhibitors against human carboxylesterase 2 in White Mulberry Root-bark.

  2016cites this paper
• Effect of Disease State on Human Carboxylesterase 1 Expression and Activity

  2016cites this paper
• Hydrolytic Fate of 3/15-Acetyldeoxynivalenol in Humans: Specific Deacetylation by the Small Intestine and Liver Revealed Using in Vitro and ex Vivo Approaches

  2016cites this paper
• Gambogic acid potentiates clopidogrel-induced apoptosis and attenuates irinotecan-induced apoptosis through down-regulating human carboxylesterase 1 and -2

  2016cites this paper
• Inhibition behavior of fructus psoraleae’s ingredients towards human carboxylesterase 1 (hCES1)

  2016influential citation
• Analysis of gene expression for microminipig liver transcriptomes using parallel long‐read technology and short‐read sequencing

  2016influential citation
• Design, synthesis, and structure-activity relationship study of glycyrrhetinic acid derivatives as potent and selective inhibitors against human carboxylesterase 2.

  2016cites this paper
• A cultured approach to canine urothelial carcinoma: molecular characterization of five cell lines

  2015cites this paper
• Metabolic implications and characterization of hepatic extracellular vesicles in drug-induced liver injury

  2015cites this paper
• Novel Approach to Chemotherapy and Administration Selection with Metronomic/Fractionated Dosing

  2015cites this paper
• Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: postnatal surge and organ-dependent regulation.

  2015cites this paper
• Decreased carboxylesterases expression and hydrolytic activity in type 2 diabetic mice through Akt/mTOR/HIF-1α/Stra13 pathway

  2015cites this paper
• Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTOR

  2015cites this paper
• Human carboxylesterase 2: Studies on the role of glycosylation for enzymatic activity

  2015cites this paper
• Fructus Psoraleae contains natural compounds with potent inhibitory effects towards human carboxylesterase 2.

  2015cites this paper
• Comparison of expression levels of fourteen genes involved in the lipid and energy metabolism in two pig breeds

  2015cites this paper
• Urethane dimethacrylate induces cytotoxicity and regulates cyclooxygenase-2, hemeoxygenase and carboxylesterase expression in human dental pulp cells.

  2014cites this paper
• Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years.

  2014cites this paper
• Glucose dominates the regulation of carboxylesterases induced by lipopolysaccharide or interleukin-6 in primary mouse hepatocytes.

  2014cites this paper
• MOLECULAR INTERACTION IN CARBOXYLESTERASES-BASED CATALYSIS: ONTOGENIC EXPRESSION AND INDUCTION THROUGH A NOVEL ELEMENT

  2014influential citation
• Human liver carboxylesterase 1 structure, polymorphism and its role in drug and prodrug activation and metabolism

  2014cites this paper
• Analytical studies of morphine and related substances using LC-MS/MS

  2014cites this paper
• A highly selective ratiometric fluorescent probe for in vitro monitoring and cellular imaging of human carboxylesterase 1.

  2014cites this paper